AI assistant
Sending…
Lite Strategy, Inc. — Director's Dealing 2023
Nov 6, 2023
34267_dirs_2023-11-06_a95c9412-5e85-40c3-8a83-afc51c41821b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2023-10-31
Reporting Person: Datoo Taheer (Director)
More from Lite Strategy, Inc.
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
Feb 17
Interim / Quarterly Report
2026
Feb 17
Director's Dealing
2026
Feb 12
Regulatory Filings
2026
Feb 12
Annual Report
2025
Dec 30
Regulatory Filings
2025
Dec 30
Proxy Solicitation & Information Statement
2025
Dec 30
Regulatory Filings
2025
Dec 30